Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) has earned an average rating of “Hold” from the seven brokerages that are presently covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a strong buy rating on the company. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $6.42.
Several equities analysts have recently issued reports on the company. Evercore ISI cut their price target on Cardlytics from $4.00 to $3.00 and set an “in-line” rating on the stock in a research note on Thursday, March 13th. Lake Street Capital dropped their target price on shares of Cardlytics from $5.00 to $3.00 and set a “hold” rating on the stock in a report on Thursday, March 13th. Finally, Needham & Company LLC restated a “hold” rating on shares of Cardlytics in a research note on Thursday, March 13th.
Check Out Our Latest Stock Analysis on CDLX
Insiders Place Their Bets
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently modified their holdings of the stock. RBF Capital LLC raised its position in shares of Cardlytics by 311.9% in the third quarter. RBF Capital LLC now owns 488,128 shares of the company’s stock worth $1,562,000 after buying an additional 369,620 shares in the last quarter. Geode Capital Management LLC raised its stake in Cardlytics by 7.5% in the third quarter. Geode Capital Management LLC now owns 1,053,178 shares of the company’s stock worth $3,371,000 after buying an additional 73,484 shares in the last quarter. Barclays PLC increased its position in Cardlytics by 223.9% during the 3rd quarter. Barclays PLC now owns 58,026 shares of the company’s stock valued at $186,000 after buying an additional 40,112 shares in the last quarter. SG Americas Securities LLC lifted its stake in Cardlytics by 38.2% during the 4th quarter. SG Americas Securities LLC now owns 19,490 shares of the company’s stock valued at $72,000 after acquiring an additional 5,392 shares during the period. Finally, Dynamic Technology Lab Private Ltd purchased a new stake in shares of Cardlytics during the 3rd quarter valued at about $153,000. 68.10% of the stock is owned by institutional investors.
Cardlytics Trading Down 11.2 %
Cardlytics stock opened at $2.15 on Friday. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.18 and a current ratio of 1.18. The firm has a market capitalization of $111.98 million, a PE ratio of -0.35 and a beta of 1.62. The business’s 50-day simple moving average is $2.87 and its 200-day simple moving average is $3.42. Cardlytics has a 52 week low of $1.77 and a 52 week high of $16.31.
Cardlytics Company Profile
Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.
See Also
- Five stocks we like better than Cardlytics
- Following Congress Stock Trades
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- Technology Stocks Explained: Here’s What to Know About Tech
- NVIDIA Insiders Sell: This Is What It Means for the Market
- What Are Dividend Challengers?
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.